Skip to main content
. 2023 Feb 1;10(2):210586. doi: 10.1098/rsos.210586

Table 1.

Preliminary list of considerations constructed in stage 1 and the corresponding item number for the stage 2 survey.

no. consideration corresponding itema
1 Do you consider the current strength of evidence in favour for the claim to be weak (as for example quantified by a Bayes factor, a very wide CI, or a p-value close to the typical alpha level of 0.05 combined with a very large sample size)? Q7 item 12
2 Given the current state of investigation of this claim in the literature, how certain are you that the claim is true? Please motivate your answer. Q5 item 5
3 Is the claim theoretically important? If yes, please elaborate. Q5 item 4
4 Do you perceive this claim to have relevant implications, for instance in practice, policy or clinical work? If yes, please elaborate. Q5 item 3
5 Please describe the design of the original study. Q7 item 2–5
6 Enter the sample size. Q7 item 1
7 Who was the sample (for example, what were inclusion and exclusion criteria)? Q7 item 2
8 How was the main outcome measured? Q7 item 19
9.1 Do you consider the outcome measure to be valid? Please motivate your answer. Q7 item 9
9.2 Do you consider the outcome measure to be reliable? Please motivate your answer. Q7 item 10
9.3 Do you consider the outcome measure to be biased? Please motivate your answer. Q7 item 11
10 Do you consider the operationalization appropriate (i.e. are the methods fitted to answer the broader research question that was posed)? Q7 item 20
11 Please describe the analysis plan and performed analysis. Q7 item 13, 14, 17
12 Please enter the observed effect size. Q7 item 6,7
13 Given the sample characteristics, was the sample a good representation of the population? In other words, do the results generalize to the population of interest? Q7 item 8
14 Is the interpretation of the current claim limited by potential confounds? If yes, please describe. Q7 item 21
15.1 Given the original study set-up, is replication readily feasible? Q9 item 2
15.2 Can this study be replicated by generally equipped labs, or are more specific experimental set-ups necessary (e.g. an eye-tracking machine, an fMRI-scanner, a sound-proof booth, etc.)? Q9 item 1
16 How could a replication overcome the issues you raised above? Please also specify the type of replication you intend to run (i.e. close or conceptual).

aItem numbers refer to the presentation in the electronic supplementary material.